NVAX--
PFE--
nvax biggest player smaller gain benefits pfizer matrix m license tech
@Trissy $NVAX The biggest player doesn't always need to take over the smaller one to gain benefits. Pfizer has already seen promise in Matrix-M and is moving to license the tech. The real chance comes when big pharma meets new vaccine science. Partnering today opens up more options tomorrow. Keep an eye on the future!
Disclaimer: The above is a summary showing certain market information. Ainvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing, All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market.Report an Issue

Comments
No comments yet